Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study

Transfusion and Apheresis Science

Volumn 36, Issue 1, 2007, Pages 57-67

  Altuntas, Fevzi ^a   Aydogdu, Ismet ^b   Kabukcu, Sibel ^c   Kocyigit, Ismail ^a   Cikim, Kerim ^b   Sari, Ismail ^a   Ali Erkut, M ^b   Eser, Bulent ^a   Ozturk, Ahmet ^a   Kaya, Emin ^b   Cetin, Mustafa ^a   Keskin, Ali ^c   Unal, Ali ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Outcome; Therapeutic plasma exchange; Thrombotic thrombocytopenic purpura; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPYRIDAMOLE; DOXYCYCLINE; FLUDARABINE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISOLONE; RIFAMPICIN; RITUXIMAB; STEROID; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BRAIN HEMORRHAGE; BRUCELLOSIS; DRUG MEGADOSE; ECCHYMOSIS; EPISTAXIS; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HEMOPTYSIS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SPLENECTOMY; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VAGINA BLEEDING;

DISEASE-FREE SURVIVAL; FEMALE; FEVER; HUMANS; MALE; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33847384624     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.05.014     Document Type: Article

References (59)

1. Bell W.R., Braine H.G., Ness P.M., and Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325 (1991) 398-403
2. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
3. Drew M.J. Therapeutic plasma exchange in hematologic diseases and dysproteinemias. In: McLeod B.C., Price T.H., and Weinstein R. (Eds). Apheresis: principles and practice. 2nd ed. (2003), AABB Press, Bethasda, MD 345-373
4. Chow T.W., Turner N.A., Chintagumpala M., McPherson P.D., Nolasco L.H., Rice L., et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 57 (1998) 293-302
5. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor - cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
6. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P., and Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89 (1997) 3097-3103
7. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
8. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
9. Moake J.L., Turner N.A., Stathopulos N.A., Nolasco L., and Hellums J.D. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78 (1986) 1456-1461
10. Altuntas F., Eser B., Sari{dotless} I., Yildiz O., Cetin M., and Unal A. Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis. Clin Appl Thromb Hemost 11 1 (2005) 105-108
11. Bennett C.L., Connors J.M., Carwile J.M., Moake J.L., Bell W.R., Tarantolo S.R., et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. New Engl J Med 342 (2000) 1773-1777
12. Nesher G., Hanna V.E., Moore T.L., Hersh M., and Osborn T.G. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24 (1994) 165-172
13. Roy V., Rizvi M.A., Vesely S.K., and George J.N. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 27 (2001) 641-646
14. Shamseddine A., Chehal A., Usta I., Salem Z., El Saghir N., and Taher A. Thrombotic thrombocytopenic purpura and pregnancy: report of 4 cases and literature review. J Clin Apher 19 (2004) 5-10
15. Thompson C.E., Damon L.E., Ries C.A., and Linker C.S. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80 (1992) 1890-1895
16. Tsai H.M., Rice L., Sarode R., Chow T.W., and Moake J.L. Antibody inhibitors to von Willebrand factor metalloproteinase and increased von Willebrand factor-platelet binding inticlopidine-associated thrombotic thrombocytopenic purpura. Ann Int Med 132 (2000) 794-799
17. Vaidya S., Abulezz S., and Lipsmeyer E. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Scand J Rheumatol 30 5 (2001) 308-310
18. Lara P.N., Coe T.L., Zhou H., Fernando L., Holland P.V., and Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 107 (1999) 573-579
19. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325 (1991) 393-397
20. Sarode R., Gottschall J.L., Aster R.H., and McFarland J.G. Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 54 (1997) 102-107
21. Hayward C.P., Sutton D.M., Carter Jr. W.H., Campbell E.D., Scott J.G., Francombe W.H., et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Int Med 154 (1994) 982-987
22. Torok T.J., Holman R.C., and Chorba T.L. Increasing mortality from thrombotic thrombocytopenic purpura in the United States: analysis of national mortality data,1968-1991. Am J Hematol 50 (1995) 84-90
23. Ahmad A., Aggarwal A., Sharma D., Dave H.P., Kinsella V., Rick M.E., et al. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura. Am J Hematol 77 2 (2004) 171-176
24. Akaogi J., Akasaka N., Yamada H., Hama N., Satoh M., Nichols C., et al. Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE. Clin Rheumatol 23 6 (2004) 541-543
25. Allan D.S., Kovacs M.J., and Clark W.F. Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy. Haematologica 86 8 (2001) 844-850
26. Kappers-Klunne M.C., Wijermans P., Fijnheer R., Croockewit A.J., van der Holt B., de Wolf J.T., et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 130 5 (2005) 768-776
27. Bohm M., Betz C., Miesbach W., Krause M., von Auer C., Geiger H., et al. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol 129 5 (2005) 644-652
28. Stein G.Y., Zeidman A., Fradin Z., Varon M., Cohen A., and Mittelman M. Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide. Int J Hematol 80 1 (2004) 94-96
29. Toyoshige M., Zaitsu Y., Okafuji K., Inoue Y., Hiroshige Y., Matsumoto N., et al. Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid. Am J Hematol 41 (1992) 69
30. Dervenoulas J., Tsirigotis P., Bollas G., Koumarianou A.A., Pappa V., Mantzios G., et al. Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases. Acta Haematol 105 4 (2001) 204-208
31. Dervenoulas J., Tsirigotis P., Bollas G., Pappa V., Xiros N., Economopoulos T., et al. Thrombotic thrombocytopenic purpura/haemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 79 (2000) 66-72
32. Ramanan A.S., Thirumala S., and Chandrasekaran V. Thrombotic thrombocytopenic purpura: a single institution experience. J Clin Apher 14 (1999) 9-13
33. Rock G., Kelton J.G., Shumak K.H., Buskard N.A., Sutton D.M., and Benny W.B. Laboratory abnormalities in thrombotic thrombocytopenic purpura. Br J Haematol 103 (1998) 1031-1036
34. Shamseddine A., Saliba T., Aoun E., Chahal A., El-Saghir N., Salem Z., et al. Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center. J Clin Apher 19 3 (2004) 119-124
35. Gasparovic V., Radonic R., Mejic S., Pisl Z., and Radman I. Possibilities and limits of treatment in patients with thrombotic thrombocytopenic purpura. Intensive Care Med 26 (2000) 1690-1693
36. Ridolfi R.L., and Bell W.R. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine 60 (1981) 413-428
37. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307 (1982) 1432-1435
38. Bandarenko N., and Brecher M.E. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apher 13 3 (1998) 133-141
39. De la Rubia J., Lopez A., Arriaga F., Cid A.R., Vicente A.I., Marty M.L., et al. Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura. Acta Haematol 102 (1999) 12-16
40. Yang C.W., Chen Y.C., Dunn P., Chang M.Y., Fang J.T., and Huang C.C. Thrombotic thrombocytopenic purpura: initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases. Renal Fail 25 (2003) 21-30
41. Ozsoylu S. High-dose intravenous methylprednisolone for thrombotic thrombocytopenic purpura. Acta Haematol 84 (1990) 110
42. Gurkan E., Baslamisli F., Guvenc B., Kilic N.B., Unsal C., and Karakoc E. Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases. Clin Lab Haematol 27 2 (2005) 121-125
43. Moake J.L., and McPherson P.D. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Am J Med 87 (1989) 9-15
44. Byrnes J.J., Moake J.L., Klug P., and Periman P. Effectivenss of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34 (1990) 169-174
45. Rock G., Shumak K.H., Sutton D.M., Buskard N.A., and Nair R.C. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 94 (1996) 383-386
46. Obrador G.T., Zeigler Z.R., Shadduck R.K., Rosenfeld C.S., and Hanrahan J.B. Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura. Am J Hematol 42 (1993) 217-220
47. Sgarabotto D., Vianello F., Scano F., Stefani P.M., Sartori R., and Girolami A. Clinical and laboratoristic remission after cryosupernatant plasma exchange in thrombotic thrombocytopenic purpura. Hematologica 83 (1998) 569-576
48. Owens M.R., Sweeney J.D., Tahhan R.H., and Fortkolt P. Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura. J Clin Apher 10 (1995) 178-182
49. Zeigler Z.R., Shadduck R.K., Gryn J.F., Rintels P.B., George J.N., Besa E.C., et al. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura. J Clin Apher 16 1 (2001) 19-22
50. Gutterman L.A., Kloster B., and Tsai H.M. Rituximab therapy for refractory thrombotic thrombocytopenic purpura. Blood Cells Mol Dis 28 3 (2002) 385-391
51. Yomtovian R., Niklinski W., Silver B., Sarode R., and Tsai H.M. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br J Haematol 124 6 (2004) 787-795
52. Aqui N.A., Stein S.H., Konkle B.A., Abrams C.S., and Strobl F.J. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apher 18 2 (2003) 51-54
53. George J.N. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96 (2000) 1223-1229
54. Mach-Pascual S., Samii K., and Beris P. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am J Hematol 52 (1996) 310-312
55. Moake J.L., and Byrnes J.J. Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 10 (1996) 485-497
56. Sarode R., McFarland J.G., Flomenberg N., Casper J.T., Cohen E.P., Drobyski W.R., et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 16 2 (1995) 271-275
57. Perez-Sanchez I., Anguita J., and Pintado T. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases. Ann Hematol 78 6 (1999) 285-287
58. Vasoo S., Thumboo J., and Fong K.Y. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs. Lupus 11 (2002) 443-450
59. Amorosi E.L., and Ultman J.E. Thrombotic thrombocytopenic purpura: report of 16 cases and review of literature. Medicine 45 (1966) 139-159